$2.42 Billion is the total value of Novo Holdings A/S's 51 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 22.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VTI | VANGUARD INDEX FDStotal stk mkt | $399,718,000 | +6.2% | 1,933,900 | 0.0% | 16.51% | +2.3% | |
| EWTX | New | EDGEWISE THERAPEUTICS INC | $181,584,000 | – | 5,587,207 | +100.0% | 7.50% | – |
| MORF | MORPHIC HLDG INC | $167,404,000 | +88.6% | 2,645,446 | 0.0% | 6.91% | +81.7% | |
| BOLT | New | BOLT BIOTHERAPEUTICS INC | $148,226,000 | – | 4,503,991 | +100.0% | 6.12% | – |
| INGN | Sell | INOGEN INC | $144,919,000 | -8.6% | 2,759,320 | -22.3% | 5.98% | -12.0% |
| BAM | BROOKFIELD ASSET MGMT INCcl a ltd vt sh | $136,658,000 | +7.8% | 3,070,957 | 0.0% | 5.64% | +3.9% | |
| AAPL | APPLE INC | $126,719,000 | -7.9% | 1,037,404 | 0.0% | 5.23% | -11.3% | |
| HRMY | Sell | HARMONY BIOSCIENCES HLDGS IN | $110,234,000 | -15.8% | 3,336,378 | -7.9% | 4.55% | -18.9% |
| NKTX | NKARTA INC | $91,918,000 | -46.5% | 2,793,864 | 0.0% | 3.80% | -48.4% | |
| CABO | Sell | CABLE ONE INC | $86,556,000 | -25.8% | 47,341 | -9.6% | 3.57% | -28.5% |
| SPRB | SPRUCE BIOSCIENCES INC | $82,823,000 | -31.7% | 4,989,336 | 0.0% | 3.42% | -34.2% | |
| PRAX | PRAXIS PRECISION MEDICINES I | $80,003,000 | -40.5% | 2,442,080 | 0.0% | 3.30% | -42.6% | |
| ALGS | ALIGOS THERAPEUTICS INC | $59,455,000 | -17.8% | 2,614,563 | 0.0% | 2.46% | -20.8% | |
| LVTX | New | LAVA THERAPEUTICS NV | $50,542,000 | – | 3,327,312 | +100.0% | 2.09% | – |
| BABA | New | ALIBABA GROUP HLDG LTDsponsored ads | $48,708,000 | – | 214,827 | +100.0% | 2.01% | – |
| MIRM | MIRUM PHARMACEUTICALS INC | $48,463,000 | +13.5% | 2,445,147 | 0.0% | 2.00% | +9.3% | |
| INZY | Sell | INOZYME PHARMA INC | $38,994,000 | -26.5% | 1,969,379 | -23.4% | 1.61% | -29.2% |
| EAR | EARGO INC | $36,817,000 | +11.4% | 737,071 | 0.0% | 1.52% | +7.3% | |
| FRLN | FREELINE THERAPEUTICS HLDGSsponsored ads | $29,043,000 | -32.6% | 2,361,229 | 0.0% | 1.20% | -35.1% | |
| CMPI | CHECKMATE PHARMACEUTICALS IN | $26,345,000 | -16.8% | 2,170,100 | 0.0% | 1.09% | -19.8% | |
| SPNE | Sell | SEASPINE HLDGS CORP | $22,986,000 | -1.6% | 1,321,006 | -1.4% | 0.95% | -5.3% |
| PTGX | PROTAGONIST THERAPEUTICS INC | $22,474,000 | +28.5% | 867,724 | 0.0% | 0.93% | +23.7% | |
| GRTX | Sell | GALERA THERAPEUTICS INC | $21,689,000 | -28.4% | 2,459,021 | -16.9% | 0.90% | -31.0% |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $19,393,000 | -50.1% | 1,962,880 | +16.5% | 0.80% | -52.0% |
| BPMC | BLUEPRINT MEDICINES CORP | $19,154,000 | -13.3% | 197,000 | 0.0% | 0.79% | -16.5% | |
| CNST | Buy | CONSTELLATION PHARMCETICLS I | $16,359,000 | -5.2% | 699,415 | +16.8% | 0.68% | -8.6% |
| INSM | Buy | INSMED INC | $15,553,000 | +8.6% | 456,631 | +6.2% | 0.64% | +4.6% |
| GLTO | GALECTO INC | $15,162,000 | -51.5% | 2,497,791 | 0.0% | 0.63% | -53.3% | |
| MIST | MILESTONE PHARMACEUTICALS IN | $14,652,000 | -13.6% | 2,530,585 | 0.0% | 0.60% | -16.8% | |
| IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $14,621,000 | -18.0% | 461,811 | +20.2% | 0.60% | -20.9% |
| AERI | Sell | AERIE PHARMACEUTICALS INC | $14,089,000 | +29.1% | 788,410 | -2.4% | 0.58% | +24.4% |
| FLXN | FLEXION THERAPEUTICS INC | $12,560,000 | -22.4% | 1,403,370 | 0.0% | 0.52% | -25.2% | |
| XENT | Buy | INTERSECT ENT INC | $10,626,000 | -7.6% | 508,922 | +1.3% | 0.44% | -11.0% |
| KNTE | KINNATE BIOPHARMA INC | $9,348,000 | -21.7% | 300,000 | 0.0% | 0.39% | -24.6% | |
| BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $8,769,000 | +23.1% | 128,300 | +54.4% | 0.36% | +18.7% |
| LUNG | PULMONX CORP | $8,556,000 | -33.7% | 187,047 | 0.0% | 0.35% | -36.2% | |
| INSP | INSPIRE MED SYS INC | $8,280,000 | +10.0% | 40,000 | 0.0% | 0.34% | +5.9% | |
| PCVX | VAXCYTE INC | $8,235,000 | -25.7% | 416,937 | 0.0% | 0.34% | -28.4% | |
| ZGNX | Buy | ZOGENIX INC | $7,943,000 | +22.0% | 406,915 | +24.9% | 0.33% | +17.6% |
| NARI | INARI MED INC | $7,727,000 | +22.6% | 72,212 | 0.0% | 0.32% | +18.1% | |
| SILK | Buy | SILK RD MED INC | $7,474,000 | +48.1% | 147,557 | +84.2% | 0.31% | +43.1% |
| LEGN | New | LEGEND BIOTECH CORPsponsored ads | $7,376,000 | – | 254,176 | +100.0% | 0.30% | – |
| VRNA | Sell | VERONA PHARMA PLCsponsored ads | $7,009,000 | -61.6% | 838,360 | -67.9% | 0.29% | -63.1% |
| SPRO | Sell | SPERO THERAPEUTICS INC | $6,902,000 | -38.3% | 468,902 | -18.7% | 0.28% | -40.5% |
| AKUS | AKOUOS INC | $6,370,000 | -30.1% | 459,290 | 0.0% | 0.26% | -32.6% | |
| CRNX | CRINETICS PHARMACEUTICALS IN | $4,147,000 | +8.3% | 271,378 | 0.0% | 0.17% | +4.3% | |
| AFIB | ACUTUS MED INC | $3,409,000 | -53.6% | 255,000 | 0.0% | 0.14% | -55.2% | |
| GRTS | New | GRITSTONE ONCOLOGY INC | $2,626,000 | – | 278,478 | +100.0% | 0.11% | – |
| PHVS | New | PHARVARIS N V | $1,399,000 | – | 50,000 | +100.0% | 0.06% | – |
| GRAY | New | GRAYBUG VISION INC | $1,164,000 | – | 209,748 | +100.0% | 0.05% | – |
| FSTX | F-STAR THERAPEUTICS INC | $377,000 | +9.6% | 34,819 | 0.0% | 0.02% | +6.7% | |
| CRVS | Exit | CORVUS PHARMACEUTICALS INC | $0 | – | -847,906 | -100.0% | -0.13% | – |
| CTLT | Exit | CATALENT INC | $0 | – | -997,349 | -100.0% | -4.45% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VANGUARD INDEX FDS | 41 | Q3 2022 | 64.7% |
| INOGEN INC | 34 | Q2 2022 | 68.8% |
| VANGUARD INTL EQUITY INDEX F | 29 | Q4 2016 | 37.6% |
| AMICUS THERAPEUTICS INC | 22 | Q3 2023 | 4.1% |
| AKEBIA THERAPEUTICS INC | 21 | Q3 2020 | 4.8% |
| VERONA PHARMA PLC | 21 | Q2 2022 | 1.9% |
| CORVUS PHARMACEUTICALS INC | 20 | Q4 2020 | 7.1% |
| INSPIRE MED SYS INC | 20 | Q3 2023 | 1.8% |
| CABLE ONE INC | 19 | Q3 2023 | 9.7% |
| FLEXION THERAPEUTICS INC | 19 | Q3 2021 | 4.7% |
View Novo Holdings A/S's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cyteir Therapeutics, Inc. | August 03, 2023 | 1,547,136 | 4.4% |
| Disc Medicine, Inc. | June 28, 2023 | 1,090,772 | 4.8% |
| Galera Therapeutics, Inc. | June 28, 2023 | 2,100,000 | 4.9% |
| VectivBio Holding AGSold out | May 26, 2023 | 0 | 0.0% |
| LanzaTech Global, Inc. | February 17, 2023 | 15,814,845 | 8.1% |
| Bolt Biotherapeutics, Inc.Sold out | January 04, 2023 | 0 | 0.0% |
| Arcellx, Inc. | December 12, 2022 | 1,750,000 | 4.0% |
| MINERVA SURGICAL INC | November 03, 2022 | 1,322,473 | 4.5% |
| Milestone Pharmaceuticals Inc. | October 24, 2022 | 1,378,538 | 4.6% |
| Galecto, Inc. | September 30, 2022 | 2,497,791 | 9.8% |
View Novo Holdings A/S's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-03-28 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-20 |
| SC 13D/A | 2024-03-20 |
| 144 | 2024-03-18 |
| 4 | 2024-03-18 |
| SC 13D/A | 2024-03-18 |
| 144 | 2024-03-14 |
| SC 13D/A | 2024-03-07 |
View Novo Holdings A/S's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.